HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application ...

A 52-year-old man hospitalized with chest pain is found to have a slow heart rate and evidence of heart block. What does an ...

The Holter ECG market is driven by increased demand for ambulatory cardiac monitoring due to rising atrial fibrillation cases ...

The Electricity Company of Ghana (ECG) is urging motorists and the general public to exercise extreme caution to prevent ...

A 94-year-old female with history of hypertension, chronic kidney disease, and hyperlipidemia presents to the emergency ...

HeartBeam (BEAT) announced its regulatory strategy following receipt of a Not Substantially Equivalent, or NSE, decision on the company’s 510(k) ...

Recognized As A Top Global Innovator In Portable ECG Technology. <li /> The company was ranked second worldwide out of 243 companies evaluated in 12-lead ECG innovation in PatentVest's“Total Cardiac ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug ...

Verrica Pharmaceuticals Inc (NASDAQ: VRCA) rose 9.7% to $7.36 in pre-market trading after gaining 31% on Wednesday. Verrica ...

TAIPEI (Taiwan News) — Taiwan’s Ostar Meditech Co. on Tuesday unveiled the second generation of its artificial intelligence heart monitor, a small device that can alert users to potential heart ...

HeartBeam is pursuing several parallel paths to address the FDA’s concerns, including a potential appeal process or resubmission of a 510 (k) application. The company noted that the appeal process ...

After centuries of domestication, pets have learned to pick up on verbal and behavioral cues to gauge their owner's mood.